Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02515110 · ClinicalTrials.gov registry record · NA
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer
A NA study of Breast Cancer and Invasive Breast Carcinoma, sponsored by Virginia Commonwealth University.
- Active
- Registry status
- NA
- Development phase
- 137
- Enrollment target
- 2
- Study locations
NCT02515110: Active NA study of Breast Cancer and Invasive Breast Carcinoma, sponsored by Virginia Commonwealth University.
NCT02515110 is a NA study of Breast Cancer and Invasive Breast Carcinoma that is active but no longer recruiting, run by Virginia Commonwealth University. The registered enrollment target is 137 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02515110, a NA study of Breast Cancer and Invasive Breast Carcinoma, is active but no longer recruiting, sponsored by Virginia Commonwealth University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
- 2
- Study locations
Study Summary
Single-arm, phase 2 study evaluating hypofractionated irradiation of breast and regional nodes in women with breast cancer. Patients will be grouped in 3 surgery-related treatment groups: 1) An intact breast following lumpectomy; 2) plans for loco regional external beam radiotherapy (EBRT) following mastectomy (with or without plans for reconstruction); and 3) plans for locoregional EBRT following mastectomy with reconstruction. Patients will be assessed for lymphedema, arm function, breast or chestwall pain, other EBRT-related adverse events, and, for patients who had a lumpectomy or mastectomy with reconstruction, cosmetic outcome.
Primary Outcome
The number of participants with incidence of lymphedema defined as ≥ 10% increase in arm circumference over baseline circumference compared to the contralateral arm measured every 6 months from the time of initiation of hypofractionated irradiation of breast and regional nodes through 3 years following the completion of radiation therapy in 2 patient cohorts: * Patients who have only had sentinel lymph node (SLN) biopsy for axillary staging * Patients who have had axillary lymph node (ALN) diss
Conditions Studied
Interventions
- RADIATION External Beam Radiation Therapy
Study Locations (2)
Virginia
- Virginia Commonwealth University/Massey Cancer Center - Richmond
- VCU Community Memorial Healthcenter - South Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2015-08-04 |
| Est. Completion | 2028-04-30 |
| Phase | NA |
What the registry record for NCT02515110 still lists
NCT02515110 is an interventional study that assigns participants to a tested intervention. The registered 137 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower).
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which External Beam Radiation Therapy is the first listed.
NCT02515110 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT02515110 about?
NCT02515110 is a clinical study titled "Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer". Single-arm, phase 2 study evaluating hypofractionated irradiation of breast and regional nodes in women with breast cancer. Patients will be grouped in 3 surgery-related treatment groups: 1) An intact breast following lumpectomy; 2) plans for loco regional external beam radiotherapy (EBRT) following...
What is the current status of trial NCT02515110?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 137 participants. The study started on 2015-08-04. Estimated completion is 2028-04-30.
What conditions does trial NCT02515110 study?
This clinical trial studies the following conditions: Breast Cancer, Invasive Breast Carcinoma, Breast Adenocarcinoma, Lobular Breast Carcinoma in Situ, Node-positive Breast Cancer.
What interventions are being tested in trial NCT02515110?
The interventions under investigation include: External Beam Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT02515110?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02515110 being conducted?
This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02515110's enrollment target sits among peer trials
137 472nd of 1224 higher than 753 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05091424 · 137 participants · Phase 1
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- NCT05655182 · 137 participants · Phase 1
A Study of BLB-201 RSV Vaccine in Infants and Children
- NCT06571669 · 137 participants · NA
BOOM-IBD2 Pivotal Clinical Trial
- NCT06644768 · 137 participants · Phase 1
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI